AG-221, a First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic <i>IDH2</i> MutationsKatharine Yen, Shinsan M. Su, Erin Artin et al.|Cancer Discovery|2017Cited by 457
Inflammation at diagnosis and cognitive impairment two years later in breast cancer patients from the Canto-Cog studyMylène Duivon, Florence Joly, Justine Lequesne et al.|Breast Cancer Research|2024Cited by 15